Engagement of the Type I Interferon Receptor on Dendritic Cells Inhibits T Helper 17 Cell Development: Role of Intracellular Osteopontin

Immunity

Volumn 29, Issue 1, 2008, Pages 68-78

  Shinohara, Mari L ^a,b   Kim, June Ho ^a   Garcia, Virgilio A ^a   Cantor, Harvey ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

MOLIMMUNO

Indexed keywords

INTERFERON RECEPTOR; INTERLEUKIN 27; OSTEOPONTIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; HELPER CELL; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T HELPER 17 CELL;

ANIMALS; CELL DIFFERENTIATION; CYTOPLASM; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOBLOTTING; INTERLEUKIN-17; MICE; MICE, MUTANT STRAINS; OSTEOPONTIN; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 44449146212     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.05.008     Document Type: Article

References (48)

1. Al Alwan M.M., Liwski R.S., Haeryfar S.M., Baldridge W.H., Hoskin D.W., Rowden G., and West K.A. Cutting edge: dendritic cell actin cytoskeletal polarization during immunological synapse formation is highly antigen-dependent. J. Immunol. 171 (2003) 4479-4483
2. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.G., and Cantor H. Eta-1 (osteopontin): an early component of Type 1(cell-mediated) immunity. Science 287 (2000) 860-864
3. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., Kuchroo V.K., Oukka M., and Weiner H.L. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8 (2007) 1380-1389
4. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., Lee J., de Sauvage F.J., and Ghilardi N. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7 (2006) 929-936
5. Benvenuti F., Hugues S., Walmsley M., Ruf S., Fetler L., Popoff M., Tybulewicz V.L., and Amigorena S. Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science 305 (2004) 1150-1153
6. Benvenuti F., Lagaudriere-Gesbert C., Grandjean I., Jancic C., Hivroz C., Trautmann A., Lantz O., and Amigorena S. Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J. Immunol. 172 (2004) 292-301
7. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197 (2003) 1073-1081
8. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
9. Burchill M.A., Nardelli D.T., England D.M., DeCoster D.J., Christopherson J.A., Callister S.M., and Schell R.F. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect. Immun. 71 (2003) 3437-3442
10. Cao Y., Doodes P.D., Glant T.T., and Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J. Immunol. 180 (2008) 922-930
11. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294 (2001) 1731-1735
12. Dalpke A.H., Schafer M.K., Frey M., Zimmermann S., Tebbe J., Weihe E., and Heeg K. Immunostimulatory CpG-DNA activates murine microglia. J. Immunol. 168 (2002) 4854-4863
13. Fitzgerald D.C., Zhang G.X., El Behi M., Fonseca-Kelly Z., Li H., Yu S., Saris C.J., Gran B., Ciric B., and Rostami A. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8 (2007) 1372-1379
14. Gilliet M., and Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195 (2002) 695-704
15. Gocke A.R., Cravens P.D., Ben L.H., Hussain R.Z., Northrop S.C., Racke M.K., and Lovett-Racke A.E. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 178 (2007) 1341-1348
16. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., and Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11 (2005) 328-334
17. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., and Baecher-Allan C. Multiple sclerosis. Immunol. Rev. 204 (2005) 208-231
18. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005) 1123-1132
19. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hovelmeyer N., Waisman A., Rulicke T., Prinz M., Priller J., et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11 (2005) 146-152
20. Huber M., Steinwald V., Guralnik A., Brustle A., Kleemann P., Rosenplanter C., Decker T., and Lohoff M. IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 20 (2008) 223-234
21. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., and Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8 (2007) 74-83
22. + T helper cells. Cell 126 (2006) 1121-1133
23. Jansson M., Panoutsakopoulou V., Baker J., Klein L., and Cantor H. Attenuated experimental autoimmune encephalomyelitis in Eta-1/osteopontin-deficient mice. J. Immunol. 168 (2002) 2096-2099
24. Kastelein R.A., Hunter C.A., and Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25 (2007) 221-242
25. Kawakami N., Lassmann S., Li Z., Odoardi F., Ritter T., Ziemssen T., Klinkert W.E., Ellwart J.W., Bradl M., Krivacic K., et al. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199 (2004) 185-197
26. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 (2007) 369-377
27. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
28. Leibundgut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., and Reis e Sousa C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8 (2007) 630-638
29. Maldonado R.A., Irvine D.J., Schreiber R., and Glimcher L.H. A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature 431 (2004) 527-532
30. O'Regan A.W., Nau G.J., Chupp G.L., and Berman J.S. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol. Today 21 (2000) 475-478
31. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., and Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6 (2005) 1133-1141
32. Paty D.W., Li D.K., and UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43 (1993) 662-667
33. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16 (2002) 779-790
34. Renkl A.C., Wussler J., Ahrens T., Thoma K., Kon S., Uede T., Martin S.F., Simon J.C., and Weiss J.M. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106 (2005) 946-955
35. Rittling S.R., Matsumoto H.N., McKee M.D., Nanci A., An X.R., Novick K.E., Kowalski A.J., Noda M., and Denhardt D.T. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13 (1998) 1101-1111
36. Sato T., Nakai T., Tamura N., Okamoto S., Matsuoka K., Sakuraba A., Fukushima T., Uede T., and Hibi T. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 54 (2005) 1254-1262
37. Shapiro S., Galboiz Y., Lahat N., Kinarty A., and Miller A. The "immunological-synapse" at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta. J. Neuroimmunol. 144 (2003) 116-124
38. Shinohara M.L., Jansson M., Hwang E.S., Werneck M.B.F., Glimcher L.H., and Cantor H. T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc. Natl. Acad. Sci. USA 102 (2005) 17101-17106
39. Shinohara M.L., Lu L., Bu J., Werneck M.B.F., Kobayashi K., Glimcher L.H., and Cantor H. Osteopontin expression is essential for IFN-α production by plasmacytoid dendritic cells. Nat. Immunol. 7 (2006) 498-506
40. Shinohara M.L., Kim H.-J., Kim J.-H., Garcia V.A., and Cantor H. Alternative translation of Osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc. Natl. Acad. Sci. USA 105 (2008) 7235-7239
41. Steinman L., and Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3 (2003) 483-492
42. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7 (2006) 937-945
43. Taniguchi T., and Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat. Rev. Mol. Cell Biol. 2 (2001) 378-386
44. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., and Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168 (2002) 4173-4183
45. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., Suda T., Sudo K., Nakae S., Iwakura Y., and Matsuzaki G. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178 (2007) 3786-3796
46. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
47. West M.A., Wallin R.P., Matthews S.P., Svensson H.G., Zaru R., Ljunggren H.G., Prescott A.R., and Watts C. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305 (2004) 1153-1157
48. Yu M., Nishiyama A., Trapp B.D., and Tuohy V.K. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64 (1996) 91-100